Ionpath, a pioneer in high-definition spatial proteomics, is revolutionizing tissue imaging to accelerate medical discovery and improve human health. Its MIBI™ (multiplexed ion beam imaging) platform breaks through the limitations of traditional immunohistochemistry (IHC), enabling a deeper understanding of the tissue microenvironment with highly multiplexed, quantitative single-cell analysis. With MIBI technology and the expertise of its pathology/data science teams, Ionpath provides actionable insights for translational/clinical research at top pharma, biotech, and research organizations.